Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | KCNJ1 | P48048 | 6/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2289284 | 0.84 | NOTUM (0.52) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL12379760 | 0.74 | NOTUM (0.53) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL2293966 | 0.74 | NOTUM (0.48) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL12379764 | 0.74 | ALDH1A1 (0.42) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL82595 | 0.70 | MAPT (0.69) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL12615985 | 0.69 | NOTUM (0.78) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL6244401 | 0.68 | NOTUM (0.50) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL29211840 | 0.67 | NOTUM (0.43) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL13823398 | 0.65 | NOTUM (0.63) | NOTUMALDH1A1MAPTLMNAHTT | |
| SCHEMBL17725782 | 0.65 | ALDH1A1 (0.62) | NOTUMALDH1A1MAPTLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090008002-A1 | Gas generant compositions | CBR3, CBR1, NOX5 | NOTUM 2783/4885ALDH1A1 1527/4885MAPT 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.